Apparent Diffusion Coefficient Changes in Prostate Cancerous and Noncancerous Regions after Endocrinotherapy
- VernacularTitle:内分泌治疗后前列腺外周带癌区和非癌区ADC值变化初步研究
- Author:
Feiyu LI
;
Xiaoying WANG
;
Jiangxi XIAO
;
Xuexiang JIANG
- Publication Type:Journal Article
- Keywords:
prostate cancer;
MR imaging;
diffusion weighted imaging;
apparent diffusion coefficient
- From:
Journal of Practical Radiology
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the changes of apparent diffusion coefficient(ADC) values after endocrinotherapy in cancerous and noncancerous regions of prostate peripheral zone.Methods 28 patients with prostate cancer proved by pathology were retrospectively evaluated in this study.The prostate peripheral zone was divided into two regions(cancerous and noncancerous regions).All patients were examined by single-shot diffusion-weighted echo-planar imaging before and after 3~6 months endocrinotherapy.ADC values of noncancerous and cancerous regions in peripheral zone were calculated and statistical analysis was performed on the data by applying either paired or independent t-test.Results Before treatment, the average ADC values in noncancerous ( n=107 ) and cancerous ( n=61 ) regions were (2.21?0.61)?10-3 mm2/s and (1.65?0.46)?10-3mm2/s, respectively, and statistic significant difference could be detected between them (t=4.36, P=0.039, independent t-test). After 3~6 months treatment, the ADC values in noncancerous and cancerous regions decreased to(1.33?0.48)?10-3 mm2/s and (1.28?0.53)?10-3mm2/s, respectively, significantly lower than those before treatment(t=5.28, P=0.024 and t=7.39, P=0.015, paired t-test),but no significant difference between noncancerous and cancerous regions was detected after endocrinotherapy (t=0.58, P=0.639, independent t-test). Conclusion After endocrinotherapy, the ADC value of cancerous and noncancerous prostate tissues both decreased. This change was more significant in noncancerous tissue and the difference of ADC values between them diminished after endocrinotherapy.
